Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging

Journal of Alzheimer's Disease

Volumn 51, Issue 3, 2016, Pages 737-745

  Moon, Yeonsil ^a   Han, Seol Heui ^a,b   Moon, Won Jin ^b  

^a Konkuk University Hospital   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

Cognitive decline; imaging; iron

Indexed keywords

IRON;

ADULT; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; BRAIN MAPPING; BRAIN REGION; CAUDATE NUCLEUS; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOBUS PALLIDUS; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POST HOC ANALYSIS; PRIORITY JOURNAL; PULVINAR; PUTAMEN; QUANTITATIVE SUSCEPTIBILITY MAPPING; THALAMUS; AGED; AGING; BRAIN; COGNITION; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; MENTAL HEALTH; METABOLISM; PROCEDURES; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; THREE DIMENSIONAL IMAGING;

AGED; AGING; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; COGNITION; DEMENTIA, VASCULAR; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; IRON; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84963738728     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-151037     Document Type: Article

References (44)

1. Ayton S, Lei P, Bush AI (2013) Metallostasis in Alzheimer's disease. Free Radic Biol Med 62, 76-89.
2. Sanders-Loehr J (1988) Involvement of oxo-bridged binuclear iron centers in oxygen transport, oxygen reduction, and oxygenation. Prog Clin Biol Res 274, 193-209.
3. Friedlich AL, Tanzi RE, Rogers JT (2007) The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element. Mol Psychiatry 12, 222-223.
4. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, Gullans SR (2002) An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem 277, 45518-45528.
5. Landschulz W, Thesleff I, Ekblom P (1984) A lipophilic iron chelator can replace transferrin as a stimulator of cell proliferation and differentiation. J Cell Biol 98, 596-601.
6. Schipper HM (2004) Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res Rev 3, 265-301.
7. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5, 863-873.
8. Kostka M, Hogen T, Danzer KM, Levin J, Habeck M,Wirth A,Wagner R, Glabe CG, Finger S, Heinzelmann U, Garidel P, Duan W, Ross CA, Kretzschmar H, Giese A (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem 283, 10992-11003.
9. Namgaladze D, Hofer HW, Ullrich V (2002) Redox control of calcineurin by targeting the binuclear Fe(2+)-Zn(2+) center at the enzyme active site. J Biol Chem 277, 5962-5969.
10. Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3, 41-51.
11. Brass SD, Chen NK, Mulkern RV, Bakshi R (2006) Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging 17, 31-40.
12. Sullivan EV, Adalsteinsson E, Rohlfing T, Pfefferbaum A (2009) Relevance of iron deposition in deep gray matter brain structures to cognitive and motor performance in healthy elderly men and women: Exploratory findings. Brain Imaging Behav 3, 167-175.
13. Ghadery C, Pirpamer L, Hofer E, Langkammer C, Petrovic K, Loitfelder M, Schwingenschuh P, Seiler S, Duering M, Jouvent E, Schmidt H, Fazekas F, Mangin JF, Chabriat H, Dichgans M, Ropele S, Schmidt R (2015) R2∗ mapping for brain iron: Associations with cognition in normal aging. Neurobiol Aging 36, 925-932.
14. Bilgic B, Pfefferbaum A, Rohlfing T, Sullivan EV, Adalsteinsson E (2012) MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 59, 2625-2635.
15. Liem MK, Lesnik Oberstein SA, Versluis MJ, Maat-Schieman ML, Haan J,Webb AG, Ferrari MD, van Buchem MA, van der Grond J (2012) 7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL. J Neurol Neurosurg Psychiatry 83, 1180-1185.
16. De Reuck JL, Deramecourt V, Auger F, Durieux N, Cordonnier C, DevosD, Defebvre L, Moreau C, Caparros-Lefebvre D, Leys D, Maurage CA, Pasquier F, Bordet R (2014) Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases: A semi-quantitative 7.0 T magnetic resonance imaging study. Eur J Neurol 21, 1026-1031.
17. Wang Y, Liu T (2015) Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker. Magn Reson Med 73, 82-101.
18. Liu C, Li W, Tong KA, Yeom KW, Kuzminski S (2015) Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging 42, 23-41.
19. Barbosa JH, Santos AC, Tumas V, Liu M, ZhengW, Haacke EM, Salmon CE (2015) Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2∗. Magn Reson Imaging 33, 559-565.
20. Moon Y, Moon WJ, Kim H, Han SH (2014) Regional atrophy of the insular cortex is associated with neuropsychiatric symptoms in Alzheimer's disease patients. Eur Neurol 71, 223-229.
21. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
23. Liu T, Liu J, de Rochefort L, Spincemaille P, Khalidov I, Ledoux JR, Wang Y (2011) Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: Comparison with COSMOS in human brain imaging. Magn Reson Med 66, 777-783.
24. Liu J, Liu T, de Rochefort L, Ledoux J, Khalidov I, ChenW, Tsiouris AJ, Wisnieff C, Spincemaille P, Prince MR, Wang Y (2012) Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 59, 2560-2568.
25. Liu T, Eskreis-Winkler S, Schweitzer AD, ChenW, Kaplitt MG, Tsiouris AJ, Wang Y (2013) Improved subthalamic nucleus depiction with quantitative susceptibility mapping. Radiology 269, 216-223.
26. Liu T, Khalidov I, de Rochefort L, Spincemaille P, Liu J, Tsiouris AJ, Wang Y (2011) A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed 24, 1129-1136.
27. Liu T,Wisnieff C, Lou M, ChenW, Spincemaille P,Wang Y (2013) Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magn Reson Med 69, 467-476.
28. Liu C, Li C, Yang J, Gui L, Zhao L, Evans AC, Yin X,Wang J (2015) Characterizing brain iron deposition in subcortical ischemic vascular dementia using susceptibility-weighted imaging: An in vivoMRstudy. Behav Brain Res 288, 33-38.
29. Dietrich RB, Bradley WG Jr (1988) Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children. Radiology 168, 203-206.
30. Won SM, Lee JH, Park UJ, Gwag J, Gwag BJ, Lee YB (2011) Iron mediates endothelial cell damage and bloodbrain barrier opening in the hippocampus after transient forebrain ischemia in rats. Exp Mol Med 43, 121-128.
31. Zhu WZ, Zhong WD, Wang W, Zhan CJ, Wang CY, Qi JP, Wang JZ, Lei T (2009) Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 253, 497-504.
32. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Siedlak SL, Tabaton M, PerryG(1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70, 2212-2215.
33. Graham SF, Nasaruddin MB, Carey M, Holscher C, McGuinness B, Kehoe PG, Love S, Passmore P, Elliott CT,Meharg AA, Green BD (2014) Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies. J Alzheimers Dis 42, 1407-1413.
34. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13, 1045-1060.
35. MoonWJ,KimHJ, RohHG,ChoiJW, HanSH(2012) Fluidattenuated inversion recovery hypointensity of the pulvinar nucleus of patients with Alzheimer disease: Its possible association with iron accumulation as evidenced by the t2(∗) map. Korean J Radiol 13, 674-683.
36. Modica CM, Zivadinov R, Dwyer MG, Bergsland N,Weeks AR, Benedict RH (2015) Iron and volume in the deep gray matter: Association with cognitive impairment in multiple sclerosis. AJNR Am J Neuroradiol 36, 57-62.
37. Benarroch EE (2015) Pulvinar: Associative role in cortical function and clinical correlations. Neurology 84, 738-747.
38. Coley N, Andrieu S, Jaros M, Weiner M, Cedarbaum J, Vellas B (2011) Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials. Alzheimers Dement 7, 602-610.
39. Liu B, Moloney A, Meehan S, Morris K, Thomas SE, Serpell LC, Hider R, Marciniak SJ, Lomas DA, Crowther DC (2011) Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J Biol Chem 286, 4248-4256.
40. Yamamoto A, Shin RW, Hasegawa K, Naiki H, Sato H, Yoshimasu F, Kitamoto T (2002) Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: Implications in the formation of neurofibrillary tangles of Alzheimer's disease. J Neurochem 82, 1137-1147.
41. Becerril-Ortega J, Bordji K, Freret T, Rush T, Buisson A (2014) Iron overload accelerates neuronal amyloid-beta production and cognitive impairment in transgenic mice model of Alzheimer's disease. Neurobiol Aging 35, 2288-2301.
42. House MJ, St Pierre TG, Kowdley KV, Montine T, Connor J, Beard J, Berger J, Siddaiah N, Shankland E, Jin LW (2007) Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients. Magn Reson Med 57, 172-180.
43. Haacke EM, Liu S, Buch S, Zheng W, Wu D, Ye Y (2015) Quantitative susceptibility mapping: Current status and future directions. Magn Reson Imaging 33, 1-25.
44. Acosta-Cabronero J, Williams GB, Cardenas-Blanco A, Arnold RJ, Lupson V, Nestor PJ (2013) In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease. Plos One 8, e81093.